Abstract
AbstractIn this mini‐review, the main differences between spherical and spheroidal particles in terms of their size, surface area, morphology, and ability to penetrate biological membranes are described. The main routes of manufacturing of prolate spheroidal particles with controlled aspect ratio are reported. There are also shown exemplary results of computational and experimental studies of spheroids useful in biomedical applications, such as controlled drug delivery and numerical studies of the passage of spheroids through biological membranes. The relations of shape, size, aspect ratio of spheroidal particles and particle–biological membrane interactions, bioavailability, and flow in blood vessels are presented. The perspectives for future studies leading to resolve crucial problems and to explain basic issues related to acting of ellipsoidal particles in biological environment are also discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
